PT3813947T - Nim para tratamento da síndrome das pernas inquietas (rls) - Google Patents

Nim para tratamento da síndrome das pernas inquietas (rls)

Info

Publication number
PT3813947T
PT3813947T PT197320211T PT19732021T PT3813947T PT 3813947 T PT3813947 T PT 3813947T PT 197320211 T PT197320211 T PT 197320211T PT 19732021 T PT19732021 T PT 19732021T PT 3813947 T PT3813947 T PT 3813947T
Authority
PT
Portugal
Prior art keywords
neem
rls
treatment
Prior art date
Application number
PT197320211T
Other languages
English (en)
Original Assignee
Vorderwuelbecke Martin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vorderwuelbecke Martin filed Critical Vorderwuelbecke Martin
Publication of PT3813947T publication Critical patent/PT3813947T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/58Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/15Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Psychology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
PT197320211T 2018-06-26 2019-06-19 Nim para tratamento da síndrome das pernas inquietas (rls) PT3813947T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18179863.8A EP3586924A1 (en) 2018-06-26 2018-06-26 Neem for treatment of rls

Publications (1)

Publication Number Publication Date
PT3813947T true PT3813947T (pt) 2022-09-06

Family

ID=62791608

Family Applications (1)

Application Number Title Priority Date Filing Date
PT197320211T PT3813947T (pt) 2018-06-26 2019-06-19 Nim para tratamento da síndrome das pernas inquietas (rls)

Country Status (9)

Country Link
US (2) US20210268058A1 (pt)
EP (2) EP3586924A1 (pt)
KR (1) KR20210023872A (pt)
AU (1) AU2019294751A1 (pt)
BR (1) BR112020024430A2 (pt)
ES (1) ES2926475T3 (pt)
PL (1) PL3813947T3 (pt)
PT (1) PT3813947T (pt)
WO (1) WO2020002101A1 (pt)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5370873A (en) * 1992-09-11 1994-12-06 Udeinya; Iroka J. Therapeutic compounds derived from the neem tree
US5395951A (en) 1992-11-17 1995-03-07 Council Of Scientific & Industrial Research Triterpene derivatives of azadirachtin having insect antifeedant and growth inhibitory activity and a process for extracting such compounds from the neem plant
DE19601482A1 (de) 1996-01-17 1997-07-24 Rembold Heinz Verfahren zur Extraktion von Inhaltsstoffen des Neem-Baumes
US7083779B2 (en) * 2003-03-26 2006-08-01 Council Of Scientific And Industrial Research Nontoxic dental care herbal formulation for preventing dental plaque and gingivitis
KR20110037462A (ko) * 2009-10-07 2011-04-13 (주)더페이스샵 님추출물을 함유하는 피부 염증 완화용 화장료 조성물
WO2015035199A1 (en) 2013-09-06 2015-03-12 Mayo Foundation For Medical Education And Research Neem compositions used for the treatment of cancer
EP3284462B1 (en) * 2016-08-17 2022-08-03 Galleon Labs LLC Strontium based compositions and formulations for pain, pruritus, and inflammation

Also Published As

Publication number Publication date
PL3813947T3 (pl) 2022-10-03
US20240050508A1 (en) 2024-02-15
EP3813947A1 (en) 2021-05-05
EP3586924A1 (en) 2020-01-01
EP3813947B1 (en) 2022-08-10
BR112020024430A2 (pt) 2021-03-23
KR20210023872A (ko) 2021-03-04
AU2019294751A1 (en) 2020-10-29
WO2020002101A1 (en) 2020-01-02
ES2926475T3 (es) 2022-10-26
US20210268058A1 (en) 2021-09-02

Similar Documents

Publication Publication Date Title
GB201804514D0 (en) Treatment of pyroptosis
GB201813876D0 (en) Treatment
EP3684342C0 (en) TREATMENT PROCEDURES
EP3894768C0 (en) METHOD FOR CRYOHARDENING
IL279497A (en) Treatment of protein in the urine
GB201706406D0 (en) Method of treatment
GB201804515D0 (en) Treatment of necroptosis
GB201800546D0 (en) Treatment
IL271211A (en) Migraine treatment
PL3813947T3 (pl) Miodla indyjska (neem) do leczenia rls
IL276107A (en) Crystalline forms of psoorstam
SG11202105877YA (en) Method of treatment
SG11202105136WA (en) Application of chidamide
GB201907305D0 (en) Treatment of conditions
IL281595A (en) Cholangiocarcinoma treatment
PT3955933T (pt) Tratamento da enxaqueca
IL263336B (en) Compounds for the treatment of symphysiolysis
GB201917253D0 (en) Treatment of conditions
GB201820236D0 (en) Method of treatment
GB201820157D0 (en) Method of treatment
GB201801249D0 (en) Methods of treatment
GB201806569D0 (en) Method of treatment
SG11202101817UA (en) Methods of inhibition
GB201804021D0 (en) Method of treatment
GB201814905D0 (en) Treatment